Clinical Trial Update: Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the use of pimecrolimus cream 1% to support reconstitution of steroid-damaged skin in adults with atopic dermatitis h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus Cream 1% (pimecrolimus)

Snippet

Sponsor: Novartis | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED